Abstract: In 1999, candidate gene screening within Anishininew (Oji-Cree) communities uncovered a novel genetic variant in the HNF-1α gene (HNF-1αG319S). Hailed as the strongest genetic predictor of type 2 diabetes (T2D) ever identified, 40% of diagnosed Manitoban youth were also found to be carriers of this variant “S-allele”. The newly discovered G319S variant was believed to drive pancreatic beta-cell dysfunction; however, youth-onset T2D is a relatively recent phenomenon. Therefore, we hypothesized that the G319S variant impairs insulin secretion when exposed to dietary carbohydrate stress but is protective in the context of traditional, off-the-land foods that are rich in fat and protein. To examine this relationship, CRISPR-Cas9 was used to knock-in the G>A.955 substitution into clonal MIN6 beta-like cells (“G319S-MIN6”) and into a C57BL/6N mouse background generating two novel experimental models. Mice were weaned onto (1) standard grain-based chow, (2) a high-fat, low-carbohydrate (HFLC) diet modelled after traditional, off-the-land foods, or (3) a high-fat, high-carbohydrate (HFHC) diet reflecting present-day Western dietary patterns. In vitro, we assessed gene expression, insulin secretion dynamics, and oxidative respiration under different macronutrient exposures. In vivo, we completed a comprehensive characterization of both male and female mice between 3- and 6-months-of-age terminating with islet isolation to assess insulin secretion and gene expression by single-cell RNA sequencing. In support of our hypothesis, the short-term consumption of a HFLC diet appears to normalize insulin secretion and glucose tolerance whereas a HFHC diet accelerates cardiometabolic dysfunction and impairs insulin secretion in G319S-expressing mice. In G319S-MIN6 cells or islets, fatty acid oxidation was increased, and gene expression changes supported a metabolic switch away from glucose respiration. Importantly, these findings demonstrate that genetics alone cannot explain T2D onset in G319S-carriers, rather gene-diet interactions, particularly a Westernized diet containing simple carbohydrates and saturated fats, leads to distinct metabolic outcomes that impact short- and long-term health. These studies may inform nutritional interventions for youth with T2D while ultimately supporting community-led efforts to access off-the-land traditional foods.
PUBLICATIONS:
Morriseau, T.S. (2022) The determinants of wellness: a perspective on diabetes and Indigenous health. Canadian Journal of Diabetes, 46(6): 551-552. doi: 10.1016/j.jcjd.2022.06.008.
Morriseau T.S., Doucette C., Dolinksy V.W. (2022). More than meets the islet: aligning nutrient and paracrine inputs with hormone secretion in health and disease. AJP Endocrinology & Metabolism, 322(5): E446-E463. 
de Bernardi Schneider, A., Osiowy, C., Hostager, R., Krarup, H., Børresen, M., Tanaka, Y., Morriseau, T., & Wertheim, J. O. (2021). Analysis of Hepatitis B Virus Genotype D in Greenland Suggests the Presence of a Novel Quasi-Subgenotype. Frontiers in Microbiology, 11, 602296. https://doi.org/10.3389/fmicb.2020.602296
Morriseau T.S., Wicklow B.A., & Lavallee B. (2020). Intergenerational Impacts of Colonization: Outcomes of Diabetes in Pregnancy for First Nations Families. Canadian Journal of Diabetes, 44(7): 573-574.
Agarwal P, Brar, N, Morriseau T, et al. (2019). Gestational Diabetes Adversely Affects Pancreatic Islet Architecture and Function in the Male Rat Offspring. Endocrinology, 160(8): 1907-1925. 
- Topic of Limesand, S.W. Commentary in Endocrinol (2019) 160:2117-2118.
- Chosen for Endocrine Society Thematic Issue on Diabetes 2019 based on high Altmetric Attention scores and Featured Article designations
- Selected as one of the Top 2019 Endocrine Studies by the Endocrine Society journals (featured in the December Endocrine News Eureka! 2019 article)
Agarwal P., Morriseau T., Kereliuk S., et al. (2018). Maternal obesity, diabetes during pregnancy and epigenetic mechanisms that influence the developmental origins of cardiometabolic disease in the offspring. Critical Reviews in Clinical Laboratory Sciences, 55(2): 71-101. 
Back to Top